Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
Unrelated Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- N/A
Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets
- Status
- COMPLETED
- Phase
- N/A
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE2
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
PACE CALL: Weight Loss Study for Childhood Leukemia Survivors
- Status
- COMPLETED
- Phase
- NA
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- NA
Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
AHN-12 Biodistribution in Advanced Leukemia
- Status
- TERMINATED
- Phase
- PHASE1